DAPAGLIFLOZIN- COST EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES IN ECUADOR
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1295
https://www.valueinhealthjournal.com/article/S1098-3015(16)01363-2/fulltext
Title :
DAPAGLIFLOZIN- COST EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES IN ECUADOR
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01363-2&doi=10.1016/j.jval.2016.03.1295
First page :
A202
Section Title :
Diabetes/Endocrine Disorders - Cost Studies
Open access? :
No
Section Order :
635